Migraine
Not recruitingStudy on Eptinezumab for Preventing Chronic Migraine in Adults
- Disease:Migraine
- Substances:Eptinezumab
Slovakia- Participants:18–64 years · 65+ years
- Substances:Eptinezumab
- Sponsor:H. Lundbeck A/S
Rare diseases
Investigational molecules
Locations
Back to Slovakia68 clinical trials in Bardejov, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Research focusing on cardiovascular diseases and treatments, including studies on hypertriglyceridemia and stroke prevention. Multiple trials are investigating innovative therapies for atherosclerotic cardiovascular disease and heart failure.
Novel approaches include testing medications like pelacarsen and obicetrapib for cardiovascular event reduction.
Comprehensive studies addressing respiratory conditions, with particular focus on asthma and COPD management. Research includes evaluation of new inhaler formulations and treatments.
Trials are evaluating both established and innovative treatment combinations for optimal patient outcomes.
Investigation of treatments for various neurological conditions, including epilepsy and depression. Studies focus on both pediatric and adult populations.
Current research includes evaluating cenobamate for seizure control and new approaches for major depressive disorder.
Tell us about your condition – we search every trial in Europe and connect you with the right site.